RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Houston, TX · Lubbock, TX · +453 more sites
Clinical trials in Lubbock, TX
34 recruiting studies have a site in or near Lubbock, TX, Texas.
Top conditions here
- Crohn's Disease (11)
- Ulcerative Colitis (9)
- Breast Cancer (3)
- Obesity (3)
- Lung Cancer (2)
- Psoriasis (2)
- Leukemia (2)
- Depression (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 34 of 34 studies
RecruitingPhase 3NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Kingwood, TX · Lubbock, TX · San Antonio, TX · +34 more sites
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
El Paso, TX · Georgetown, TX · Houston, TX · +98 more sites
RecruitingPhase 3NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Sponsor: Takeda
Baytown, TX · Bellaire, TX · +50 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denton, TX · +84 more sites
RecruitingPhase 3NCT06966700
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sponsor: Merck Sharp & Dohme LLC
Abilene, TX · Dallas, TX · +61 more sites
RecruitingPhase 3NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +238 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Cedar Park, TX · Dallas, TX · Fort Worth, TX · +37 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Garland, TX · Lubbock, TX · +9 more sites
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Lubbock, TX · +137 more sites
RecruitingPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Cedar Park, TX · Denton, TX · Garland, TX · +27 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Garland, TX · Georgetown, TX · Houston, TX · +27 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites
RecruitingPhase 2NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor: AbbVie
Cedar Park, TX · El Paso, TX · Garland, TX · +61 more sites
RecruitingPhase 3NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Carrollton, TX · Dallas, TX · Lubbock, TX · +36 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Austin, TX · +106 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +122 more sites
RecruitingPhase 3NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Lubbock, TX · Mesquite, TX · San Antonio, TX · +31 more sites
RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Abilene, TX · Allen, TX · Dallas, TX · +173 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites
RecruitingPhase 3NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Sponsor: Takeda
Baytown, TX · Bellaire, TX · Houston, TX · +16 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Amarillo, TX · Angleton, TX · Baytown, TX · +1223 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Austin, TX · Corpus Christi, TX · Dallas, TX · +161 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +115 more sites
RecruitingPhase 4NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Sponsor: Aurinia Pharmaceuticals Inc.
Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
RecruitingNot applicableNCT07740291
Tirzepatide Impact Assessment Study
Sponsor: Texas Tech University
Lubbock, TX
RecruitingNot applicableNCT06580964
Heat and Exercise in Aging as Therapy (HEAT)
Sponsor: Texas Tech University
Lubbock, TX
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Abilene, TX · Amarillo, TX · Dallas, TX · +1226 more sites
RecruitingPhase 1 / Phase 2NCT06755827
Pilot Testing a Novel Approach to Pediatric Obesity Treatment
Sponsor: Texas Tech University
Lubbock, TX
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Abilene, TX · Baytown, TX · Conroe, TX · +809 more sites
RecruitingPhase 4NCT06903819
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Sponsor: Texas Tech University Health Sciences Center
Lubbock, TX
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites
Not yet recruitingNot applicableNCT06668272
Small Changes Clinical Weight Loss Trial
Sponsor: The University of Texas Health Science Center, Houston
Houston, TX · Lubbock, TX
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.